LncRNA HOXA‐AS2 promotes the progression of epithelial ovarian cancer via the regulation of miR‐372

Yanli Wang,Wenjing Shao
DOI: https://doi.org/10.3892/ol.2024.14527
2024-06-27
Oncology Letters
Abstract:Long non‐coding RNAs, such as homeobox A cluster antisense RNA2 (HOXA‐AS2) are understood to be involved in tumor growth and development of numerous cancers. However, the role of HOXA‐AS2 in the progression of human epithelial ovarian cancer (EOC) remains unclear. In the present study, the expression of HOXA‐AS2 was found to be upregulated in EOC tissues compared with noncancerous tissues, and to be strongly correlated to an advanced Federation International of Gynecology and Obstetrics grade and poor prognosis. Knockdown of HOXA‐AS2 in the EOC cells inhibited cell proliferation, invasion and migration, as well as inducing cell apoptosis. The ENCORI database was used to screen the microRNAs (miRNAs/miRs) that bound to HOXA‐AS2, and one was tested using RNA pull‐down and luciferase reporter assays. It was demonstrated that HOXA‐AS2 functioned through the competing endogenous RNA mechanism to regulate miR‐372. It was also demonstrated that the downregulation of miR‐372 reversed the inhibitory effects of the knockdown of HOXA‐AS2 in EOC cells. These results indicated that HOXA‐AS2 promoted EOC progression by regulating the miR‐372, which suggests that HOXA‐AS2 may be a therapy target for EOC.
oncology
What problem does this paper attempt to address?